1 completed, 1 recruiting, 1 withdrawn. 3 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Recruiting 1, Withdrawn 1 |
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Stage II Rectal Cancer: new trials by email Literature Review of Stage II Rectal Cancer trials Research Report on Stage II Rectal Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery Complete responders and Non-complete responders, Chemoradiation + EBRT Boost, Chemoradiation + HDRBT Boost - Stage II Rectal Cancer, Organ Preservation | Phase 2 / Phase 3 | Recruiting | Sir Mortimer B. Davis - Jewish General Hospital | 131 | 2017-04-25 | 2026-06-30 |
| Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma Capecitabine, 5-FU, Leucovorin - Stage II Rectal Cancer, Stage III Rectal Cancer | Phase 1 / Phase 2 | Withdrawn | University of Texas Southwestern Medical Center | 2011-03-01 | 2020-08-20 | |
| Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum oxaliplatin, fluorouracil, external beam radiation therapy - Adenocarcinoma of the Rectum, Stage II Rectal Cancer | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 24 | 2000-07-01 | 2013-01-16 |
Rectal Neoplasms (3)
Colorectal Neoplasms (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Gastrointestinal Diseases (3) · Gastrointestinal Neoplasms (3) · Intestinal Diseases (3) · Intestinal Neoplasms (3) · Neoplasms (3) · Neoplasms by Site (3) · Rectal Diseases (3)
Fluorouracil (2) · Oxaliplatin (2) · Capecitabine (1) · Chemoradiotherapy (1) · Leucovorin (1) · Radiation (1)
National Cancer Institute (NCI) (1) · Sir Mortimer B. Davis - Jewish General Hospital (1) · University of Texas Southwestern Medical Center (1)
United States (3) · Canada (1)
David Ryan (1) · Te Vuong, MD (1)
U10CA031946 (1)